Clinical Trial Update: An Open-Label, Multi-Center Trial in the Treatment of Subjects With Moderate to Severe Plaque Type Psoriasis [Phase 2]

View source ↗

Summary

A Phase 2 open-label trial evaluating a treatment for moderate to severe plaque psoriasis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Snippet

Sponsor: Stiefel, a GSK Company | Conditions: Psoriasis | Phase 2 | Status: COMPLETED